Commercial descriptions sometimes suggest that adding an arginine-based counterion makes BPC-157 dramatically more stable or highly available after oral consumption
Whitney Bowe, clinical assistant professor of dermatology at the Icahn School of Medicine at Mount Sinai Medical Center in New York
Specifically, this peptide seemed to suppress the growth of two types of cancer cells in experimental settings: SH-SY5Y neuroblastoma cells, which are a model for studying nerve cell behavior and pathology, and U937 histiocytic lymphoma cells, which are used to study the immune system's response to cancer
GLP-1 receptor agonists (GLP-1RAs) were designed to reproduce endogenous GLP-1 biology while overcoming the peptides pharmacokinetic liabilities
Why This Matters for Dermatology Traditionally, GLP-1 receptor agonists have been prescribed by endocrinologists or primary care physicians for the management of type 2 diabetes and obesity
In addition, surgery patients required fewer prescriptions for diabetes, blood pressure, and cholesterol management
